What is the current Price Target for the Marker Therapeutics, Inc. stock?

The average Marker Therapeutics, Inc. target price is $8.17. This is 410.42% higher than the current stock price. The highest price target is 681.25%, the lowest is 150.00%. 3 Analysts have issued a price target Marker Therapeutics, Inc. 2026 .

How high will the Marker Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Marker Therapeutics, Inc. stock will rise. The performance of stocks, including the Marker Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Marker Therapeutics, Inc. stock today?

The performance of Marker Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Marker Therapeutics, Inc. stock fall?

The decline in Marker Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Marker Therapeutics, Inc. Forecast, price target & analysts

$1.60

5.33% yesterday

Nasdaq, Jun 13, 10:00 pm CET

ISIN

US57055L1070

Symbol

MRKR

Reports

Quarter | Annual

Index

NASDAQ Composite

Overview Dividends Analysts Charts News Strategies

Marker Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Marker Therapeutics, Inc. Classifications & Recommendation:

Buy

100%

Marker Therapeutics, Inc. Price Target

Target Price	$8.17
Price	$1.60
Potential	410.42% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Marker Therapeutics, Inc. 2026 . The average Marker Therapeutics, Inc. target price is $8.17. This is 410.42% register free of charge higher than the current stock price. The highest price target is $12.50 681.25% register free of charge , the lowest is $4.00 150.00% register free of charge .
	A rating was issued by 3 analysts: 3 Analysts recommend Marker Therapeutics, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Marker Therapeutics, Inc. stock has an average upside potential 2026 of 410.42% register free of charge . Most analysts recommend the Marker Therapeutics, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	6.59	2.70
	99.09%	59.04%

3 Analysts have issued a sales forecast Marker Therapeutics, Inc. 2025 . The average Marker Therapeutics, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$6.6m	99.09%
2025	$2.7m 59.04% Unlock
2026	$2.9m 7.16% Unlock
2027	$27.9m 865.55% Unlock
2028	$123m 340.81% Unlock
2029	$240m 94.61% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		2.01

Based on analysts' sales estimates for 2025, the Marker Therapeutics, Inc. stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	0.95	83.93%
2025	2.01 111.75% Unlock
2026	1.88 6.68% Unlock
2027	0.19 89.64% Unlock
2028	0.04 77.31% Unlock
2029	0.02 48.53% Unlock

Current	3.35	64.01%
2025	7.08 111.14% Unlock
2026	6.61 6.68% Unlock
2027	0.68 89.64% Unlock
2028	0.16 77.32% Unlock
2029	0.08 48.62% Unlock

Marker Therapeutics, Inc....

Current Marker Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
WBB Securities	Locked ➜ Locked	Locked	Apr 01 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Mar 05 2025
Ladenburg Thalmann	Locked ➜ Locked	Locked	Oct 21 2024

Analyst Rating	Date
Locked WBB Securities: Locked ➜ Locked	Apr 01 2025
Locked Canaccord Genuity: Locked ➜ Locked	Mar 05 2025
Locked Ladenburg Thalmann: Locked ➜ Locked	Oct 21 2024

Discover more stocks with a high price target

TUI 69.05%

Alibaba Group Holding Ltd 42.41%

NIO ADR 41.21%

MongoDB 32.46%

Adidas 31.10%

BioNTech SE - ADR 30.67%

Deutsche Telekom 26.66%

Tencent Holdings Ltd. 25.42%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now